The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
UMC Utrecht
National Institutes of Health Clinical Center (CC)
Aveni Foundation
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
University of California, Davis
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Centre Antoine Lacassagne
Duke University
AstraZeneca
Essen Biotech
A2 Biotherapeutics Inc.
Eli Lilly and Company
Angiex, Inc.
St. Jude Children's Research Hospital
Poseida Therapeutics, Inc.
MacroGenics
Poitiers University Hospital
Unity Health Toronto
University of Colorado, Denver
General Oncology, Inc.
City of Hope Medical Center
Daiichi Sankyo
SN BioScience
University of Nebraska
Takeda
Eli Lilly and Company
EXoPERT
HealthPartners Institute
Adela, Inc
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
Eli Lilly and Company
Wake Forest University Health Sciences
Var2 Pharmaceuticals
MOMA Therapeutics
Mayo Clinic
Memorial Sloan Kettering Cancer Center